New drug 8M2D enters first human tests for Alzheimer's
Disease control
Not yet recruiting
This study is the first time a new drug called 8M2D is being tested in humans. The main goal is to see if it is safe and how the body handles it. The study involves healthy adults and people with early Alzheimer's disease. Researchers will also check if the drug can lower amyloid…
Phase: PHASE1 • Sponsor: Cenna Biosciences Inc. • Aim: Disease control
Last updated May 08, 2026 12:02 UTC